Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers

• US 8,753,555 B2
• Filed: 04/11/2011
• Issued: 06/17/2014
• Est. Priority Date: 12/01/2006
• Status: Active Grant

• Current Assignee: Tepha Incorporated (Becton, Dickinson & Co)
• Original Assignee: Tepha Incorporated (Becton, Dickinson & Co)
• Inventors: Rizk, Said, Martin, David P., Ho, Kicherl, Williams, Simon F.
• Primary Examiner(s): Yoon, Tae H
• Application Number:
  US13/084,388
• Publication Number:
  US 20110189475A1
• Time in Patent Office: 1,163 Days
• Field of Search: 523/113, 523/115, 528/354, 264/177.17, 264/211.12, 264/210.7, 428/336
• US Class Current: 264/210.7
• CPC Class Codes: A61L 27/18 obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
• CPC Class Codes: A61L 27/34 Macromolecular materials
• CPC Class Codes: A61L 31/10 Macromolecular materials
• CPC Class Codes: B29C 55/005 characterised by the choice of materials
• CPC Class Codes: B29C 55/04 uniaxial, e.g. oblique
• CPC Class Codes: B29C 55/12 biaxial
• CPC Class Codes: B29K 2067/00 Use of polyesters or derivatives thereof, as moulding material
• CPC Class Codes: B29K 2067/046 PLA, i.e. polylactic acid or polylactide
• CPC Class Codes: B29K 2995/006 Bio-degradable, e.g. bioabsorbable, bioresorbable or bioerodible
• CPC Class Codes: C08L 67/04 Polyesters derived from hydroxycarboxylic acids, e.g. lactones C08L67/06 takes precedence
• CPC Class Codes: Y10T 428/263 Coating layer not in excess of 5 mils thick or equivalent
• CPC Class Codes: Y10T 428/265 1 mil or less

Abstract

Continuous processing methods for making absorbable polymeric films with one or more of the following properties: high toughness, low modulus, high tensile strength, and thickness less than 10 mm, more preferably less than 1 mm, and more preferably less than 100 μm, have been developed. In the preferred embodiment, the polymer is a polyhydroxyalkanoate, and in the most preferred embodiment, the polymer comprises 4-hydroxybutyrate. A particularly preferred embodiment is a film of poly-4-hydroxybutyrate or copolymer thereof, wherein the film has a tensile strength greater than 5.5 kgf/mm², tensile modulus less than 181 kgf/mm², and elongation at break from 10-500%, wherein the film is derived by a continuous process such as melt extrusion or solvent casting, followed by orientation to more than 25% of the film'"'"'s original length in one or more directions. These can be used for a variety of purposes including fabrication of medical devices.

Claims

1. A non-porous film of an oriented poly-4-hydroxybutyrate polymer or a copolymer thereof,

wherein the film has an elongation at break from 10-500%, and

wherein the film is derived by drying the polymer or copolymer to less than 0.01% (w/w) water, melt extruding the polymer or copolymer, then orienting the film by stretching the film by more than 25% of the film'"'"'s original length in one or more directions.

2. A device comprising the film of claim 1.

3. The device of claim 2 wherein the film is a component of a device selected from the group consisting of a stent, stent graft, stent coating, drug delivery device, device for temporary wound or tissue support, repair patch, tissue engineering scaffold, retention membrane, anti-adhesion membrane, tissue separation membrane, hernia repair device, device coating, cardiovascular patch, catheter balloon, vascular closure device, sling, biocompatible coating, rotator cuff repair device, meniscus repair device, adhesion barrier, guided tissue repair/regeneration device, articular cartilage repair device, nerve guide, tendon repair device, intracardiac septal defect repair device, atrial septal defect repair devices, patent foramen ovale (PFO) closure devices, left atrial appendage (LAA) closure device, pericardial patch, bulking agent, filling agent, vein valve, heart valve, bone marrow scaffold, meniscus regeneration device, ligament and tendon graft, ocular cell implant, spinal fusion device, imaging device, skin substitute, dural substitute, bone graft substitute, wound dressing, and hemostat.

4. The film of claim 1, wherein the thickness of the film is less than 10.0 mm.

5. The film of claim 1 further comprising a prophylactic, diagnostic, or therapeutic agent.

6. The film of claim 1 further comprising additives selected from the group consisting of plasticizers, nucleants, compatibilizers, porogens, radiolabelled substances, imaging agents, radiopaque markers, contrast agents, anti-oxidants, dyes, viscosity modifiers, and odor control agents.

11. The film of claim 1, wherein the thickness of the film is less than 1.0 mm.

12. The film of claim 1, wherein the thickness of the film is less than 100 μ

m.

13. The film of claim 1, having a toughness greater than 10.0 kgf/mm².

14. The film of claim 1 having a toughness of about 184 kgf/mm² and a tensile strength of about 14.13 kgf/mm².

15. The film of claim 1, consisting of a copolymer selected from the group consisting of a copolymer of 4-hydroxybutyrate and 3-hydroxybutyrate, and a copolymer of 4-hydroxybutyrate and glycolic acid.

16. The film of claim 1, wherein the film is monoaxially or biaxially oriented.

7. A method of producing a non-porous oriented poly-4-hydroxybutyrate polymer or copolymer film, wherein the film has an elongation at break from 10-500%,

comprising drying the polymer or copolymer to less than 0.01% (w/w) water,

melt extruding the polymer or copolymer to form a film, and

orienting the film by stretching the film by more than 25% of the film'"'"'s original length in one or more directions.

8. The method of claim 7 further comprising forming the film into a component of a device selected from the group consisting of a stent, stent graft, stent coating, drug delivery device, device for temporary wound or tissue support, repair patch, tissue engineering scaffold, retention membrane, anti-adhesion membrane, tissue separation membrane, hernia repair device, device coating, cardiovascular patch, catheter balloon, vascular closure device, sling, biocompatible coating, rotator cuff repair device, meniscus repair device, adhesion barrier, guided tissue repair/regeneration device, articular cartilage repair device, nerve guide, tendon repair device, intracardiac septal defect repair device, atrial septal defect repair devices, patent foramen ovale (PFO) closure devices, left atrial appendage (LAA) closure device, pericardial patch, bulking agent, filling agent, vein valve, heart valve, bone marrow scaffold, meniscus regeneration device, ligament and tendon graft, ocular cell implant, spinal fusion device, imaging device, skin substitute, dural substitute, bone graft substitute, wound dressing, and hemostat.

17. The method of claim 7, consisting of a copolymer selected from the group consisting of a copolymer of 4-hydroxybutyrate and 3-hydroxybutyrate, and a copolymer of 4-hydroxybutyrate and glycolic acid.

18. The method of claim 7, wherein the film is monoaxially or biaxially oriented.

9. A method of using a device comprising a non-porous oriented poly-4-hydroxybutyrate polymer or copolymer film,

wherein the film has an elongation at break from 10-500%,

wherein the film is derived by a continuous process of solvent casting or melt extrusion of the polymer or copolymer to form a film, followed by orienting the film by stretching the film by more than 25% of the film'"'"'s original length in one or more directions,

comprising inserting or implanting the device into an individual in need thereof.

10. The method of claim 9 wherein the device is selected from the group consisting of a stent, stent graft, stent coating, drug delivery device, device for temporary wound or tissue support, repair patch, tissue engineering scaffold, retention membrane, anti-adhesion membrane, tissue separation membrane, hernia repair device, device coating, cardiovascular patch, catheter balloon, vascular closure device, sling, biocompatible coating, rotator cuff repair device, meniscus repair device, adhesion barrier, guided tissue repair/regeneration device, articular cartilage repair device, nerve guide, tendon repair device, intracardiac septal defect repair device, atrial septal defect repair devices, patent foramen ovale (PFO) closure devices, left atrial appendage (LAA) closure device, pericardial patch, bulking agent, filling agent, vein valve, heart valve, bone marrow scaffold, meniscus regeneration device, ligament and tendon graft, ocular cell implant, spinal fusion device, imaging device, skin substitute, dural substitute, bone graft substitute, wound dressing, and hemostat.